DM
DiaMedica Therapeutics Inc.
DMAC · NASDAQ
$7.94 +1.15% (+$0.09)
1M +24.26%
Market Cap $391.2M
P/E Ratio -
Div. Yield -
ROE 77.68%
Bulios Fair Price
$6.3
20.7% downside
Trenutna cena
$7.94
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DMAC trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 10.20x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 20.80%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 100.92%
Asset turnover 0.00x
ROE 77.68%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 6.72x
Int. coverage N/A
Stability
77 /100
Stable Beta 0.97x
Profitable years 0
EPS volatility 9.27%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DMAC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dietrich John Pauls
Employees
35
Headquarters
Minneapolis
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report